Onyx Pharmaceuticals, Inc.
Overview
Onyx Pharmaceuticals, Inc., a subsidiary of Amgen Inc., focuses on the development and commercialization of innovative therapies targeting the molecular mechanisms that drive cancer. It is particularly recognized for its contributions to the field of hematology and oncology.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Onyx Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.